Immunic, Inc. (IMUX)

Last Closing Price: 14.17 (2026-06-03)

EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Immunic, Inc. (IMUX) EBITDA Margin data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
--
$-32.59M
--
--
$33.23M
$-33.23M
$0.65M
$-32.59M
$-32.59M
$-32.59M
$-32.59M
$-32.59M
$-32.59M
$-33.23M
$-33.20M
30.14M
30.14M
$-1.08
$-1.08
Balance Sheet Financials
$188.76M
$0.57M
$0.98M
$189.74M
$38.36M
--
$0.15M
$38.51M
$151.23M
$151.23M
$151.23M
13.62M
Cash Flow Statement Financials
$-17.30M
$-0.00M
$188.64M
$15.48M
$186.63M
$171.15M
$4.47M
--
--
Fundamental Metrics & Ratios
4.92
--
--
--
--
--
--
--
EBITDA Margin
--
--
--
$-17.30M
--
--
--
--
--
--
--
-21.55%
-21.55%
-17.17%
-21.55%
$11.10
$-0.57
$-0.57